Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024
GlobeNewswire
PDUFA Target Action Date of June 26, 2024Eight posters including two oral presentations support potential of ensifentrine,
an..